O'BRIEN STEPHANIE MONAGHAN reported 1 transaction at APELLIS PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/8/2026ACC: 0001492422-26-000099
Director
Since Jan 2019
+5.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
5.75K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+5.75K
Price / share
—
Trade value
—
% of position
New position
4/6/2026
0.00→5.75K
Total
Net shares
+5.75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/6/2026 | J · J | +5.75K | — | — | New position | 0.00 | 5.75K |
| Total | +5.75K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned25.67K
Total
25.67K direct25.67K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25.67K | Direct |
| Total | 25.67K | 25.67K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported